Profil
Walter A. Blättler was the founder of Semma Therapeutics, Inc. founded in 2015, where he held the title of Vice President-Manufacturing.
He currently holds the position of Chairman at Formation Biologics Corp.
and 35Pharma, Inc. Dr. Blättler's former positions include Director-Pre Clinical Development at Proterris (Portugal) -.
Investigação e Desenvolvimento from 2009 to 2011, Director at Bristol-Myers Squibb FCT bêta, Inc. from 2014 to 2020, Executive Vice President-Science & Technology at ImmunoGen, Inc. from 1987 to 2007, Independent Member-Supervisory Board at MorphoSys AG from 2007 to 2015, and Vice President-Development at CoStim Pharmaceuticals, Inc. from 2012 to 2014.
Dr. Blättler's education includes a graduate degree from Swiss Federal Institute of Technology in 1973 and a doctorate degree from Swiss Federal Institute of Technology in 1978.
Postes actifs de Walter Blättler
| Sociétés | Poste | Début |
|---|---|---|
35Pharma, Inc.
35Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in designing and developing of TGF-beta superfamily therapeutics | Président | - |
Anciens postes connus de Walter Blättler
| Sociétés | Poste | Fin |
|---|---|---|
Bristol-Myers Squibb FCT bêta, Inc.
Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-tumor activity medication treatment | Directeur/Membre du Conseil | 21/09/2020 |
| MORPHOSYS AG | Directeur/Membre du Conseil | 08/05/2015 |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Corporate Officer/Principal | 01/01/2014 |
Proterris (Portugal) - Investigação e Desenvolvimento
Proterris (Portugal) - Investigação e Desenvolvimento Pharmaceuticals: GenericHealth Technology Develops small-molecule drugs for the treatment of inflammation-related diseases | Corporate Officer/Principal | 01/01/2011 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 05/03/2007 |
Formation de Walter Blättler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proterris (Portugal) - Investigação e Desenvolvimento
Proterris (Portugal) - Investigação e Desenvolvimento Pharmaceuticals: GenericHealth Technology Develops small-molecule drugs for the treatment of inflammation-related diseases | Health Technology |
Bristol-Myers Squibb FCT bêta, Inc.
Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-tumor activity medication treatment | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Health Technology |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Health Technology |
Formation Biologics Corp.
Formation Biologics Corp. Miscellaneous Commercial ServicesCommercial Services Operates clinical stage company that designs and develops bio therapeutics for treatment of cancer & fibrotic diseases | Commercial Services |
35Pharma, Inc.
35Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in designing and developing of TGF-beta superfamily therapeutics | Health Technology |
















